Study guide
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia
EDAIC Part I European Diploma in Anaesthesiology and Intensive Care
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The EDAIC Part I Examination
1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy
2 Chapter 2: Anatomy for Anaesthesia and Intensive Care
2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart
3 Chapter 3: Respiratory and Cardiovascular Physiology
3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics
4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology
4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach
5 Chapter 5: Endocrine and Haematological Physiology
5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders
6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric
6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation
7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics
7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity
8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics
8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents
9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics
9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy
10 Chapter 10: Haematological and Internal Medicine Pharmacology
10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions
11 Chapter 11: Physics, Clinical Measurement and Medical Equipment
11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis
12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units
13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal
13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)
14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management
14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting
15 Chapter 15: Coexisting Disease and Preoperative Investigations
15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease
16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia
16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia
17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia
18 Chapter 18: Anaesthetic Complications and Specialty Settings
18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery
19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management
20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support
20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination
21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes
21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate
22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies
22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure
23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics
23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration
24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies
24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy
25 Chapter 25: Burns, Environmental Emergencies and Patient Transport
25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia
Key Takeaways Explain This Topic AI
Differential neuraxial blockade proceeds according to fiber diameter and myelination: sympathetic preganglionic B fibers are blocked 2 to 4 dermatomes higher than sensory A-delta/C fibers, which are blocked 2 dermatomes higher than motor A-alpha fibers.
Hyperbaric bupivacaine (0.5% with 8% dextrose, specific gravity 1.026) gravitates to the dependent thoracic kyphosis (T4) in the supine position; placing the patient in Trendelenburg precipitously advances cephalad spread toward cervical segments.
High thoracic sympathectomy (T1-L2) induces profound hypotension via venous capacitance pooling, while blockade of T1-T4 cardioaccelerator fibers triggers severe bradycardia, further exacerbated by the Bainbridge and Bezold-Jarisch reflexes.
An epidural test dose containing 3 mL lidocaine 1.5% with epinephrine 1:200,000 (15 mcg) detects intravascular injection by a heart rate rise >= 10 bpm (classically >= 20 bpm) or a systolic blood pressure rise >= 15 mmHg within about a minute, and subarachnoid injection by rapid dense spinal block within 3 minutes.
Post-dural puncture headache results from CSF leakage exceeding choroid plexus production (0.35 mL/min), causing caudal brain sag and traction on CN VI; an autologous epidural blood patch (about 20 mL) is the definitive treatment, although complete lasting relief after one patch is not guaranteed.
Last updated: October 2026
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia
Neuraxial anaesthesia—encompassing spinal (subarachnoid), epidural, and caudal blockade—constitutes the cornerstone of regional anaesthetic practice in modern surgical care. Mastery requires a precise understanding of vertebral column anatomy, the biophysics of drug distribution within the cerebrospinal fluid (CSF) and epidural space, the physiological consequences of sympathetic denervation, and the immediate recognition and protocolized management of life-threatening complications.
- 1. Neuroanatomy and Mechanisms of Neuraxial Blockade
- Anatomical Layers and Drug Diffusion
During needle advancement from skin to the subarachnoid space along the midline, the needle traverses the following structures in sequential order:
- Skin and subcutaneous adipose tissue
- Supraspinous ligament (dense fibrous band bridging vertebral spinous tips)
- Interspinous ligament (thin membranous collagenous bands)
Ligamentum flavum ("yellow ligament" rich in elastic fibers, offering distinct tactile resistance before a sudden release)
Epidural space (potential space containing internal vertebral venous plexus of Batson, lymphatics, fat, and mixed spinal nerve roots)
- Dura mater (tough fibroelastic outer meningeal layer)
- Arachnoid mater (avascular delicate cellular membrane; closely applied to the inner surface of the dura)
- Subarachnoid space (containing CSF, spinal cord, and trabeculae)
In spinal anaesthesia, local anaesthetic (LA) is deposited directly into the subarachnoid space, mixing with CSF. The drug acts primarily on spinal nerve rootlets (radicles) within the subarachnoid space, which lack a thick protective epineurium and perineurium, rendering them exquisitely sensitive to conduction block. Secondary sites of action include the dorsal root ganglia, the posterior horn superficial laminae (Lissauer's tract and substantia gelatinosa), and the superficial ascending and descending long tracts of the spinal cord.
In epidural anaesthesia, the solution is deposited into the epidural space outside the dural sac. To achieve neural blockade, the local anaesthetic must diffuse across the dural sleeves into the CSF, as well as transit through the intervertebral foramina into the paravertebral space to act directly on mixed spinal nerves and dorsal root ganglia.
Differential Nerve Blockade
Nerve fibers exhibit differential sensitivity to local anaesthetics based on axonal diameter, degree of myelination, and conduction velocity. This gives rise to predictable spatial and functional gradients across spinal dermatomes: +-----------------------------------------------------------------------------------------------------+
- | DIFFERENTIAL NEURAXIAL BLOCKADE |
- | |
- | Cephalad Level [ Sympathetic Block ] (B fibers, small unmyelinated C fibers) |
- | ^ - 2 to 4 dermatomes higher than sensory block |
- | | - Results in peripheral venodilation and loss of vasomotor tone |
- | | |
- | Middle Level [ Sensory Block ] (A-delta & C fibers: cold/pain; A-beta: light touch) |
- | | - Temperature (cold) loss occurs 1 to 2 segments higher than pinprick |
- | | - Pinprick sensation lost before light touch and proprioception |
- | v |
- | Caudad Level [ Motor Block ] (A-alpha & A-gamma fibers: heavily myelinated, large) |
- | - 2 dermatomes lower than sensory block |
- | - Preserves deep tendon reflexes at higher segmental levels |
- +-----------------------------------------------------------------------------------------------------+
Sympathetic Autonomic Blockade: Mediated by small preganglionic myelinated B fibers ( 1 − 3 μ m 1 - 3\text{ }\mu\text{m} 1 − 3 μ m ) and unmyelinated C fibers. Because critical conduction block requires exposure of fewer nodes of Ranvier (or lower threshold concentrations), the sympathetic block extends 2 to 4 dermatomal segments cephalad to the sensory block level.
Sensory Blockade: Mediated by thinly myelinated A δ A\delta A δ fibers ( 2 − 5 μ m 2 - 5\text{ }\mu\text{m} 2 − 5 μ m , mediating fast/sharp pain and temperature) and unmyelinated C fibers ( 0.4 − 1.2 μ m 0.4 - 1.2\text{ }\mu\text{m} 0.4 − 1.2 μ m , slow/burning pain), followed by myelinated A β A\beta A β fibers ( 6 − 12 μ m 6 - 12\text{ }\mu\text{m} 6 − 12 μ m , touch and pressure). Clinically, loss of cold sensation (ice or alcohol swab) occurs approximately 1 to 2 segments higher than loss of sharp pinprick sensation.
Motor Blockade: Mediated by large, heavily myelinated A α A\alpha A α motor neurons ( 12 − 20 μ m 12 - 20\text{ }\mu\text{m} 12 − 20 μ m ) and A γ A\gamma A γ spindle fibers. Complete conduction failure requires a high concentration of local anaesthetic bathed across ≥ 3 \ge 3 ≥ 3 consecutive nodes of Ranvier. Consequently, motor block terminates approximately 2 dermatomes caudad to the sensory block.
- 2. Spinal Anaesthesia: Baricity, Positioning, and Hemodynamics
- Baricity and Spread Dynamics
Baricity is the ratio of the density of the injected local anaesthetic solution to the density of the patient's CSF at body temperature ( 37 ∘ C 37^\circ\text{C} 3 7 ∘ C ):
Baricity = ρ solution ρ CSF \text{Baricity} = \frac{\rho_{\text{solution}}}{\rho_{\text{CSF}}} Baricity = ρ CSF ρ solution
Normal human CSF has a density of 1.0003 − 1.0008 g/mL 1.0003 - 1.0008\text{ g/mL} 1.0003 − 1.0008 g/mL at 37 ∘ C 37^\circ\text{C} 3 7 ∘ C (mean specific gravity ≈ 1.0063 \approx 1.0063 ≈ 1.0063 ).
Solution Classification Specific Gravity / Baricity Typical Formulation Gravitational Behavior & Clinical Application
Hyperbaric Baricity > 1.000 > 1.000 > 1.000 ( Density > 1.0010 g/mL \text{Density} > 1.0010\text{ g/mL} Density > 1.0010 g/mL ) Bupivacaine 0.5 % 0.5\% 0.5% in 8 % 8\% 8% dextrose (Specific gravity ≈ 1.026 − 1.027 \approx 1.026 - 1.027 ≈ 1.026 − 1.027 ) Sinks to dependent areas of the spinal canal under gravity. In the supine position, pools in the thoracic kyphosis ( T 4 − T 5 T4 - T5 T 4 − T 5 ) and sacral hollow ( S 2 S2 S 2 ). Placing patient in Trendelenburg rapidly drives drug cephalad into the cervical spine!
Isobaric Baricity ≈ 1.000 \approx 1.000 ≈ 1.000 ( Density = 0.9998 − 1.0008 g/mL \text{Density} = 0.9998 - 1.0008\text{ g/mL} Density = 0.9998 − 1.0008 g/mL ) Plain bupivacaine 0.5 % 0.5\% 0.5% or ropivacaine 0.5 % 0.5\% 0.5% in normal saline (Specific gravity ≈ 1.006 \approx 1.006 ≈ 1.006 ) Spreads independently of gravity or positioning . Distribution is dictated by total administered mass, injection volume, and CSF turbulence. Ideal for lower extremity or perineal procedures where level stability is desired regardless of post-induction tilting.
Hypobaric Baricity < 1.000 < 1.000 < 1.000 ( Density < 0.9995 g/mL \text{Density} < 0.9995\text{ g/mL} Density < 0.9995 g/mL ) Plain bupivacaine diluted with sterile water ( 0.1 − 0.2 % 0.1 - 0.2\% 0.1 − 0.2% , specific gravity ≈ 0.998 \approx 0.998 ≈ 0.998 ) Rises against gravity to non-dependent areas . Excellent for prone jackknife position (anorectal surgery) or unilateral operative hip in lateral decubitus positioning (non-dependent operative side up).
Spinal Curvature and Positioning
In the supine horizontal position, the vertebral column exhibits two distinct anatomical curvatures: the lordotic cervical and lumbar curves, and the kyphotic thoracic and sacrococcygeal curves. The two most dependent (lowest) points in the supine canal are T4 (thoracic kyphosis apex) and S2 (sacral hollow), whereas the highest point is L3 (lumbar lordosis apex). Consequently, hyperbaric solutions injected at L3-L4 gravitate downward into the sacral curve and cephalad over the L3 peak into the thoracic kyphosis, naturally settling at the T4-T5 dermatomal level .
- Warning
- Clinical Trap: Trendelenburg Post-Hyperbaric Injection
Tilting a patient into the Trendelenburg (head-down) position within the first 15 to 20 minutes following subarachnoid injection of hyperbaric bupivacaine eliminates the protective cranial rise of the upper thoracic spine, allowing the dense solution to pour into the upper thoracic and cervical cord, triggering high spinal anaesthesia or total spinal collapse!
Cardiovascular and Respiratory Sequelae of Neuraxial Blockade
Hemodynamic Consequences:
Systemic Vasodilation: Sympathetic preganglionic fibers emerge from the spinal cord between T1 and L2 . Blockade of these fibers obliterates vascular smooth muscle tone. Arteriolar vasodilation causes a modest decrease in systemic vascular resistance (SVR); however, venodilation produces profound venocapacitance pooling in the splanchnic and lower extremity vascular beds, precipitously reducing venous return ( V R VR V R ), stroke volume ( S V SV S V ), and cardiac output ( C O CO CO ).
Profound Bradycardia: When the block ascends to encompass T1 - T4 , preganglionic cardioaccelerator sympathetic fibers are blocked. Unopposed vagal parasympathetic innervation produces marked bradycardia. Furthermore, precipitous drops in right atrial filling pressure and central venous pressure ( C V P CVP C V P ) deactivate stretch receptors, triggering paradoxical vagal bradycardia via the Bainbridge reflex and the Bezold-Jarisch reflex (intracardiac mechanoreceptors sensing an underfilled, hypercontractile left ventricle, causing abrupt vagally mediated bradycardia, peripheral vasodilation, and cardiac arrest).
Respiratory Consequences:
The diaphragm is innervated by the phrenic nerve arising from the cervical plexus ( C3, C4, C5 ; "C3, 4, 5 keeps the diaphragm alive"). High thoracic spinal blockade sparing the cervical plexus preserves resting tidal breathing and diaphragmatic excursion.
However, blockade of thoracic spinal nerves ( T 1 − T 11 T1 - T11 T 1 − T 11 ) paralyses intercostal muscles, and blockade of T 6 − L 1 T6 - L1 T 6 − L 1 paralyses abdominal wall musculature. This severely compromises active expiration, forceful coughing, and clearance of bronchial secretions, causing peak expiratory flow rate ( P E F R PEFR PEFR ) and forced expiratory volume to drop by 20 − 30 % 20 - 30\% 20 − 30% .
Patients frequently complain of subjective air hunger or dyspnea despite normal S p O 2 SpO_2 Sp O 2 and arterial blood gas values due to the loss of sensory proprioceptive feedback from the moving thoracic chest wall.
- 3. Epidural and Caudal Anaesthesia
- Identification of the Epidural Space
The epidural space is identified using specialized blunted needles (most commonly the Tuohy needle , featuring a curved 15-30° Huber tip designed to push the dura away rather than puncture it, and guide catheter advancement):
Loss of Resistance (LOR) Technique: The needle is advanced through subcutaneous tissue and engaged into the interspinous ligament and ligamentum flavum, where extreme resistance to injection is felt on the syringe plunger. Upon breaching the inner border of the ligamentum flavum into the epidural space, an unmistakable, sudden "loss of resistance" occurs.
Saline vs. Air: LOR with saline is internationally preferred over air. LOR with air introduces risks of venous air embolism (if epidural veins are cannulated), patchy/unilateral analgesia (air bubbles insulate spinal nerve roots), pneumocephalus with catastrophic immediate headache if accidental dural puncture occurs, and spinal cord compression in infants.
Hanging Drop Technique (Gutierrez's Sign): Relies on the subatmospheric (negative) pressure present within the epidural space (typically − 1 to − 7 cmH 2 O -1\text{ to }-7\text{ cmH}_2\text{O} − 1 to − 7 cmH 2 O ), generated by transmission of negative intrapleural pressure through intervertebral foramina, especially in sitting thoracic epidural placements. A drop of saline placed on the hub of the needle is sucked inward upon entering the space.
The Epidural Test Dose
Accidental intravascular injection (into the engorged epidural venous plexus) or accidental intrathecal injection (subarachnoid migration) of full epidural doses can lead to catastrophic local anaesthetic systemic toxicity (LAST) or total spinal arrest. A dedicated test dose is mandatory:
Standard Formulation: 3 mL 3\text{ mL} 3 mL of lidocaine 1.5 % 1.5\% 1.5% with epinephrine 1 : 200,000 1:200{,}000 1 : 200 , 000 ( 15 μ g 15\text{ }\mu\text{g} 15 μ g of epinephrine and 45 mg 45\text{ mg} 45 mg of lidocaine).
Intravascular Detection Criteria: Injection of the 15 μ g 15\text{ }\mu\text{g} 15 μ g epinephrine bolus into a blood vessel produces an acute, transient increase in heart rate ≥ 10 bpm \ge 10\text{ bpm} ≥ 10 bpm (classically ≥ 20 bpm \ge 20\text{ bpm} ≥ 20 bpm ) or an increase in systolic blood pressure ≥ 15 mmHg \ge 15\text{ mmHg} ≥ 15 mmHg within about 20 − 40 seconds 20 - 40\text{ seconds} 20 − 40 seconds , accompanied by systemic symptoms such as palpitations, dizziness, or metallic taste, and ECG changes (T-wave amplitude decrease ≥ 25 % \ge 25\% ≥ 25% ). In patients on beta-blockers, elderly individuals, or labouring parturients during active contractions, heart rate changes may be blunted; a rise in systolic blood pressure of ≥ 15 mmHg \ge 15\text{ mmHg} ≥ 15 mmHg or stroke volume monitoring must be prioritized.
Intrathecal Detection Criteria: The 45 mg 45\text{ mg} 45 mg of lidocaine is sufficient to produce rapid, profound sensory numbness and motor paralysis of the lower extremities within 3 minutes 3\text{ minutes} 3 minutes , confirming subarachnoid placement.
Caudal Anaesthesia in Paediatric and Adult Practice
Caudal anaesthesia involves accessing the sacral epidural space through the sacral hiatus , which is formed by the failure of the fifth (and occasionally fourth) sacral vertebral laminae to fuse in the midline, bounded laterally by the sacral cornua and roofed by the sacrococcygeal ligament . [ SACRAL POSTERIOR ANATOMY ]
- |
- [ Posterior Superior Iliac Spines ]
- (PSIS - S2 level)
- |
- v
- [ Sacral Canal / Dura ]
- (Dural sac terminates at S2 adults, S3 infants!)
- |
- v
- [ Sacral Cornua (Bilateral) ]
- |
- [ Sacrococcygeal Ligament ]
- |
- v
- [ Sacral Hiatus ]
Dural Sac Termination Anatomy:
In adults, the dural sac and subarachnoid space terminate at the lower border of S2 .
In neonates and infants, the dural sac terminates lower, at S3 . Because the distance between the sacrococcygeal ligament and the dural cuff in neonates can be as short as 5 − 10 mm 5 - 10\text{ mm} 5 − 10 mm , the risk of unintentional dural puncture and total spinal is markedly elevated if the needle is advanced steeply into the canal. The needle should be inserted at 45 ∘ 45^\circ 4 5 ∘ until a "pop" through the ligament is felt, then flattened almost parallel to the skin and advanced no more than 1 − 3 mm 1 - 3\text{ mm} 1 − 3 mm into the sacral canal.
Armitage Dosing Formula (Paediatric Caudal Analgesia): Dosing of bupivacaine 0.125 − 0.2 % 0.125 - 0.2\% 0.125 − 0.2% (with or without epinephrine 1 : 200,000 1:200{,}000 1 : 200 , 000 or clonidine 1 μ g/kg 1\text{ }\mu\text{g/kg} 1 μ g/kg ):
- Lumbosacral block (circumcision, hypospadias, inguinal hernia): 0.5 mL/kg 0.5\text{ mL/kg} 0.5 mL/kg
- Thoracolumbar block (up to T10, umbilical hernia, orchiopexy): 1.0 mL/kg 1.0\text{ mL/kg} 1.0 mL/kg
Mid-thoracic block (up to T6): 1.25 mL/kg 1.25\text{ mL/kg} 1.25 mL/kg (maximum recommended volume: 20 mL 20\text{ mL} 20 mL ).
- 4. Complications of Neuraxial Anaesthesia
- Post-Dural Puncture Headache (PDPH)
Pathophysiology: Loss of dural integrity results in continuous trans-dural leakage of CSF into the epidural space at a rate that exceeds the compensatory biosynthetic rate of the choroid plexus (normal CSF production is approximately 0.35 mL/min 0.35\text{ mL/min} 0.35 mL/min or ∼ 500 mL/day \sim 500\text{ mL/day} ∼ 500 mL/day ). The resulting intracranial hypotension depletes the hydrostatic fluid cushion supporting the brain. When the patient assumes an erect posture, the cerebral hemispheres and brainstem sag caudally. This exerts downward mechanical traction on anchoring, pain-sensitive meninges, tentorium, bridging dural veins, and cranial nerves:
CN VI (Abducens nerve): Possesses the longest intracranial intradural course, running across the sharp petrous apex of the temporal bone into Dorello's canal. Downward traction causes mechanical stretch, producing unilateral or bilateral lateral rectus palsy, manifested clinically as diplopia .
CN VIII (Vestibulocochlear nerve): Traction or endolymphatic pressure alterations produce low-frequency hearing loss, subjective tinnitus , dizziness, and nausea.
Clinical Presentation: A severe, fronto-occipital, throbbing headache that is strictly postural : rapidly exacerbated within 15 to 30 seconds of sitting or standing upright, and completely or substantially relieved when assuming the recumbent supine horizontal position. Associated with photophobia, nausea, vomiting, and neck stiffness.
Needle Risk Factors:
Gauge: Larger bore needles yield higher leak rates (16-18G Tuohy carries a 50 − 70 % 50 - 70\% 50 − 70% PDPH incidence upon accidental dural puncture).
Needle Tip Geometry: Cutting needles (Quincke) slice cleanly through dural and arachnoid fibers, creating non-sealing gaping defects with high PDPH rates. Pencil-point needles (Whitacre, Sprotte) separate and stretch elastocollagenous fibers without cutting, triggering local edema that rapidly seals the defect; 25G or 27G pencil-point needles yield PDPH incidences < 1 % < 1\% < 1% .
Bevel Orientation: If using a cutting needle, aligning the bevel parallel to the longitudinal axis of the spine separates rather than severs longitudinally oriented dural fibers, halving the incidence of PDPH.
Management:
Conservative: Horizontal bed rest, vigorous hydration ( > 3 L/day >3\text{ L/day} > 3 L/day ), regular analgesics (paracetamol, NSAIDs), oral caffeine ( 300 mg 300\text{ mg} 300 mg q6h) or IV caffeine sodium benzoate ( 500 mg 500\text{ mg} 500 mg in 1000 mL 1000\text{ mL} 1000 mL saline, causing cerebral vasoconstriction).
Definitive Treatment: Autologous Epidural Blood Patch (EBP):
Technique: Performed under strict aseptic conditions. An operator secures epidural access at the same interspace or one interspace below the primary dural puncture site, while an assistant draws 15 − 20 mL 15 - 20\text{ mL} 15 − 20 mL of sterile autologous venous blood from the patient's antecubital fossa. The blood is injected slowly into the epidural space until the patient reports distinct fullness, pressure, or dull ache in the back or buttocks.
Mechanism: Dual effect: (1) immediate transmission of hydrostatic volume pressure into the thecal sac, elevating intracranial pressure and halting brain sag; (2) sustained formation of a dense gelatinous fibrin clot over the dural defect, providing permanent mechanical seal while tissue repair occurs.
Efficacy: Most patients improve after the first patch, but reported rates of complete and lasting relief vary widely between studies, and some patients need a second patch.
Spinal Epidural Hematoma and Abscess
Spinal Epidural Hematoma (SEH): A catastrophic neurosurgical emergency caused by rupture of the internal vertebral venous plexus into the non-distensible spinal canal. The expanding hematoma compresses the spinal cord or cauda equina, leading to ischemic necrosis.
Clinical Triad: Severe, localized back pain with radicular radiation, rapidly progressive motor weakness (flaccid paraparesis), and sphincter dysfunction (urinary retention or fecal incontinence).
Diagnostic & Therapeutic Algorithm: Immediate emergent urgent MRI of the whole spine. If hematoma is confirmed, decompressive surgical laminectomy must be performed within 8 to 12 hours of onset; decompression beyond 12 hours rarely reverses permanent paraplegia.
Spinal Epidural Abscess (SEA): Triad of severe back pain, fever/leukocytosis, and progressive neurological deficits. Common pathogen is Staphylococcus aureus ( > 60 % >60\% > 60% ). Requires immediate blood cultures, MRI, high-dose IV antibiotic therapy, and urgent surgical evacuation/drainage.
ASRA Coagulation Guidelines for Neuraxial Blocks
To mitigate the risk of spinal epidural hematoma, the American Society of Regional Anesthesia and Pain Medicine (ASRA, 4th edition, Horlocker et al. 2018) recommends timing intervals between anticoagulant administration, neuraxial puncture, and catheter removal. The 2022 ESAIC/ESRA guideline uses similar principles with some drug-specific differences (for example, shorter intervals for low-dose DOAC prophylaxis), so follow the local protocol:
Anticoagulant Agent Mandatory Hold Time Prior to Block / Puncture Safe Catheter Manipulation & Removal Resumption of Drug Post-Puncture or Catheter Removal
Unfractionated Heparin (UFH) (IV therapeutic) Hold 4 − 6 hours 4 - 6\text{ hours} 4 − 6 hours ; verify normal aPTT Remove 4 − 6 hours 4 - 6\text{ hours} 4 − 6 hours after stopping; check aPTT Restart 1 hour 1\text{ hour} 1 hour after puncture or catheter removal
Unfractionated Heparin (UFH) (Subcutaneous prophylaxis) Hold 4 − 6 hours 4 - 6\text{ hours} 4 − 6 hours for low dose ( 5000 IU 5000\text{ IU} 5000 IU q8-12h); 12 hours 12\text{ hours} 12 hours for 7500 − 10,000 IU 7500 - 10{,}000\text{ IU} 7500 − 10 , 000 IU q12h Remove 4 − 6 hours 4 - 6\text{ hours} 4 − 6 hours after the last low dose Next dose ≥ 1 hour \ge 1\text{ hour} ≥ 1 hour after puncture or catheter removal
LMWH (Prophylactic) (e.g. Enoxaparin 40 mg 40\text{ mg} 40 mg once daily) Hold ≥ 12 hours \ge 12\text{ hours} ≥ 12 hours Hold ≥ 12 hours \ge 12\text{ hours} ≥ 12 hours prior to removal Restart ≥ 4 hours \ge 4\text{ hours} ≥ 4 hours post-catheter removal
LMWH (Therapeutic) (e.g. Enoxaparin 1 mg/kg 1\text{ mg/kg} 1 mg/kg q12h or 1.5 mg/kg 1.5\text{ mg/kg} 1.5 mg/kg daily) Hold ≥ 24 hours \ge 24\text{ hours} ≥ 24 hours Remove catheter before therapeutic dosing starts First dose ≥ 24 hours \ge 24\text{ hours} ≥ 24 hours after puncture and ≥ 4 hours \ge 4\text{ hours} ≥ 4 hours after catheter removal
Warfarin (Coumarin) Discontinue 5 days 5\text{ days} 5 days prior; verify INR < 1.4 < 1.4 < 1.4 Remove catheter only when INR < 1.5 < 1.5 < 1.5 Can resume evening of surgery with catheter in situ if monitored
Clopidogrel Discontinue 5 − 7 days 5 - 7\text{ days} 5 − 7 days prior Catheter may stay 1 − 2 days 1 - 2\text{ days} 1 − 2 days if restarted without a loading dose Maintenance dose after removal; loading dose ≥ 6 hours \ge 6\text{ hours} ≥ 6 hours after removal
Direct Factor Xa Inhibitors (Rivaroxaban, Apixaban, Edoxaban) Hold 72 hours 72\text{ hours} 72 hours Avoid indwelling neuraxial catheters Restart ≥ 6 hours \ge 6\text{ hours} ≥ 6 hours post-removal
Dabigatran (Direct Thrombin Inhibitor) Hold 72 hours 72\text{ hours} 72 hours ( CrCl ≥ 80 \text{CrCl} \ge 80 CrCl ≥ 80 ), 96 hours 96\text{ hours} 96 hours ( 50 − 79 50 - 79 50 − 79 ), 120 hours 120\text{ hours} 120 hours ( 30 − 49 mL/min 30 - 49\text{ mL/min} 30 − 49 mL/min ) Avoid indwelling neuraxial catheters Restart ≥ 6 hours \ge 6\text{ hours} ≥ 6 hours post-removal
Total Spinal Anaesthesia
Mechanism: Accidental injection of a massive epidural dose into the subarachnoid or subdural space, or uncontrolled massive cephalad migration of subarachnoid local anaesthetic to the brainstem and cisterna magna.
Clinical Manifestations: Rapid ascending paralysis within minutes: numbness in upper limbs and fingers ( C 6 − C 8 C6 - C8 C 6 − C 8 ), profound arterial hypotension and unrecordable blood pressure, severe bradycardia or asystole ( T 1 − T 4 T1 - T4 T 1 − T 4 sympathetic denervation), respiratory arrest/apnea (phrenic nerve C 3 − C 5 C3 - C5 C 3 − C 5 block and medullary hypoperfusion), loss of consciousness, and fixed, widely dilated pupils (blockade of parasympathetic ciliary ganglion fibers).
Immediate Resuscitation Protocol:
Airway & Breathing: Call for help immediately; secure airway via rapid sequence endotracheal intubation; deliver 100 % O 2 100\%\text{ O}_2 100% O 2 with positive pressure ventilation.
Circulation: Rapid IV fluid bolus of balanced crystalloid ( 1000 − 2000 mL 1000 - 2000\text{ mL} 1000 − 2000 mL ); tilt table left/elevate legs; administer immediate IV vasopressors: ephedrine 10 − 20 mg 10 - 20\text{ mg} 10 − 20 mg , phenylephrine 100 − 200 μ g 100 - 200\text{ }\mu\text{g} 100 − 200 μ g , and without hesitation IV epinephrine ( 10 − 100 μ g 10 - 100\text{ }\mu\text{g} 10 − 100 μ g boluses) if profound bradycardia and collapse ensue; administer atropine 0.5 − 1.0 mg 0.5 - 1.0\text{ mg} 0.5 − 1.0 mg for vagal bradycardia.
Supportive Care: Mechanical ventilation and vasopressor support must be maintained until the local anaesthetic redistributes and metabolizes (typically 1 − 3 hours 1 - 3\text{ hours} 1 − 3 hours ); patients recover completely without neurological deficit if cerebral hypoxemia and ischemia were prevented.
Transient Neurological Symptoms (TNS) vs. Cauda Equina Syndrome (CES)
Feature Transient Neurological Symptoms (TNS) Cauda Equina Syndrome (CES)
Definition Transient, painful radicular syndrome characterized by burning/aching in lower back, buttocks, and radiating down legs True structural neurotoxic or compressive destruction of lumbosacral nerve roots forming the cauda equina
Onset & Duration Onset within 12 − 24 hours 12 - 24\text{ hours} 12 − 24 hours post-recovery; resolves spontaneously within 2 − 5 days 2 - 5\text{ days} 2 − 5 days Onset immediately post-block or evolving over hours; permanent or prolonged severe neurological deficits
Neurological Examination Completely normal : no motor weakness, no sensory deficits, intact reflexes, normal bowel/bladder function Severe focal deficits : flaccid lower limb paraparesis, sensory loss in "saddle" perineal distribution ( S 3 − S 5 S3 - S5 S 3 − S 5 ), absent ankle reflexes, fecal incontinence, urinary retention
Etiology & Risk Factors Hyperbaric 5 % 5\% 5% lidocaine carries the highest incidence ( 15 − 35 % 15 - 35\% 15 − 35% ); lithotomy position, outpatient knee arthroscopy High-concentration local anaesthetic pooling (microcatheter spinal continuous lidocaine 5 % 5\% 5% ), massive epidural hematoma
Management Symptomatic: reassurance, non-steroidal anti-inflammatory drugs (NSAIDs), heating pads Urgent MRI of spine; emergent neurosurgical decompression; high-dose steroids; supportive bowel/bladder care